AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
暂无分享,去创建一个
J. Thariat | P. Franco | D. Alterio | P. Bonomo | E. Russi | A. Merlotti | E. Orlandi | A. Argenone | S. Racadot | D. Musio | S. Ursino | M. Lapeyre | M. Maddalo | P. Graff | G. Fanetti | F. Dionisi | Y. Pointreau | J. Bourhis | F. De Felice | L. Belgioia | A. Di Rito | M. Scricciolo | I. D’Onofrio | E. D'angelo
[1] A. Juloori,et al. Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer. , 2022, International Journal of Radiation Oncology, Biology, Physics.
[2] U. Alsharif,et al. Impact of stratified resection margin classification on local tumor control and survival in patients with oral squamous cell carcinoma , 2021, Journal of surgical oncology.
[3] M. Bullock,et al. Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma , 2021, Journal of Otolaryngology - Head & Neck Surgery.
[4] R. Orecchia,et al. The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors. , 2021, Oral Diseases.
[5] T. B. Bakker Schut,et al. Performance of Intraoperative Assessment of Resection Margins in Oral Cancer Surgery: A Review of Literature , 2021, Frontiers in Oncology.
[6] G. Poissonnet,et al. Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] T. Yen,et al. Precision Adjuvant Therapy Based on Detailed Pathological Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long Term Outcome Comparison of CGMH and NCCN Guidelines. , 2020, International journal of radiation oncology, biology, physics.
[8] A. Shiotani,et al. Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Vidhyadharan,et al. Predictors of locoregional control in stage I/II oral squamous cell carcinoma classified by AJCC 8th edition. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] B. Burtness,et al. Pathologic staging changes in oral cavity squamous cell carcinoma: Stage migration and implications for adjuvant treatment , 2019, Cancer.
[11] M. Varvares,et al. Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta-analysis , 2019, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[12] Nofisat Ismaila,et al. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Batstone,et al. Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With Histologic Risk Factors: Are We Over-Treating? , 2018, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[14] W. Thorstad,et al. Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil , 2017, Cancer.
[15] S. Nuyts,et al. Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma? , 2017, Cancers.
[16] Bin Xu,et al. A Proposal to Redefine Close Surgical Margins in Squamous Cell Carcinoma of the Oral Tongue , 2017, JAMA otolaryngology-- head & neck surgery.
[17] Simion I. Chiosea,et al. Intraoperative Margin Assessment in Early Oral Squamous Cell Carcinoma. , 2017, Surgical pathology clinics.
[18] N. Lee,et al. Adjuvant radiation in the TORS era: Is there a benefit to omitting the tumor bed? , 2017, Practical radiation oncology.
[19] Brian O'Sullivan,et al. Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[20] Jia Hui Ng,et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study , 2017, Head & neck.
[21] A. Popovtzer,et al. Radiotherapy in early‐stage tongue squamous cell carcinoma with minor adverse features , 2017, Head & neck.
[22] S. Roman,et al. Proposing prognostic thresholds for lymph node yield in clinically lymph node‐negative and lymph node‐positive cancers of the oral cavity , 2016, Cancer.
[23] T. Roques,et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.
[24] S. Billan,et al. Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: A prospective randomized controlled study , 2016, Head & neck.
[25] N. Robinson,et al. Delphi methodology in health research: how to do it?☆ , 2015 .
[26] K. Markou,et al. The role of neck dissection and postoperative adjuvant radiotherapy in cN0 patients with PNI-positive squamous cell carcinoma of the oral cavity. , 2014, Oral oncology.
[27] Jonathan R. Clark,et al. Clinical Nodal Stage is a Significant Predictor of Outcome in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Negative Neck Metastases: Results of the International Consortium for Outcome Research , 2013, Annals of Surgical Oncology.
[28] S. Rogers,et al. Systematic review of the current evidence in the use of postoperative radiotherapy for oral squamous cell carcinoma. , 2012, The British journal of oral & maxillofacial surgery.
[29] A. Ostuni,et al. Compartmental tongue surgery: Long term oncologic results in the treatment of tongue cancer. , 2011, Oral oncology.
[30] Johannes A Langendijk,et al. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy. , 2010, International journal of radiation oncology, biology, physics.
[31] K. Keum,et al. Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy , 2010, Radiation oncology.
[32] V. Resto,et al. Oral Cavity Squamous Cell Carcinoma and the Clinically N0 Neck: The Past, Present, and Future of Sentinel Lymph Node Biopsy , 2010, Current oncology reports.
[33] D. Berger,et al. Perineural invasion in cancer , 2009, Cancer.
[34] M. van Glabbeke,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[35] J. Jacobs,et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.
[36] S. Rogers,et al. The prognostic implications of the surgical margin in oral squamous cell carcinoma. , 2003, International journal of oral and maxillofacial surgery.
[37] J G Batsakis,et al. Surgical excision margins: a pathologist's perspective. , 1999, Advances in anatomic pathology.
[38] D. Schuller,et al. The prognostic significance of metastatic cervical lymph nodes , 1980, The Laryngoscope.
[39] T. Yen,et al. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease. , 2012, International journal of radiation oncology, biology, physics.
[40] Peir-Rong Chen,et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. , 2010, Oral oncology.
[41] TNM Atlas , 1989, UICC International Union Against Cancer / Union Internationale Contre le Cancer.